无凝血酶可流动明胶在全关节置换术中的应用:一项倾向性评分匹配比较研究
该回顾性研究纳入2018至2024年单中心初次全膝关节置换术(TKA)和全髋关节置换术(THA)患者,按术中是否使用无凝血酶可流动明胶(FG)进行2:1倾向性评分匹配。结果显示FG组TKA和THA的总失血量、隐性失血量及输血率均显著降低,血栓栓塞事件发生率组间无显著差异,多因素分析提示FG使用是总失血量减少的独立预测因素。
要点
- FG组TKA总失血量899.0 mL vs 非FG组1,122.1 mL,THA为1,021.8 mL vs 1,328.4 mL,均显著降低。
- FG组输血率TKA 4.3% vs 12.9%,THA 8.87% vs 19.69%,均低于非FG组。
- 深静脉血栓和肺栓塞等血栓栓塞事件发生率组间无显著差异(P > 0.05)。
核心结论
- 本研究发现FG可有效减少TKA和THA的围手术期失血量和输血率,且不增加下肢血栓形成或其他术后并发症风险。
研究设计与样本
- 回顾性分析2018至2024年单中心初次TKA和THA患者,按术中是否使用FG分组,FG组按2:1倾向性评分匹配非FG组,匹配因素包括人口学特征、合并症和手术因素。
- 共纳入612例TKA患者(非FG组233例,FG组117例)和844例THA患者(非FG组391例,FG组203例),平均随访超过两年(最长六年)。
- 主要结局包括失血量、输血率、血栓栓塞事件及其他围手术期并发症,并采用回归分析评估术中FG使用对TKA和THA总失血量的影响。
主要发现
- TKA总失血量FG组899.0 mL vs 非FG组1,122.1 mL,THA总失血量FG组1,021.8 mL vs 非FG组1,328.4 mL,FG组均显著降低。
- TKA隐性失血量FG组789.1 mL vs 非FG组1,010.8 mL,THA隐性失血量FG组858.6 mL vs 非FG组1,169.9 mL,FG组均显著降低。
- 输血率TKA FG组4.3% vs 非FG组12.9%,THA FG组8.87% vs 非FG组19.69%,FG组均更低。
- 包括深静脉血栓和肺栓塞在内的血栓栓塞事件发生率组间无显著差异(P > 0.05)。
- 多因素分析进一步确定FG使用是总失血量减少的独立预测因素。
关键数值与推荐
- TKA总失血量FG组899.0 mL vs 非FG组1,122.1 mL;THA总失血量FG组1,021.8 mL vs 非FG组1,328.4 mL。
- TKA隐性失血量FG组789.1 mL vs 非FG组1,010.8 mL;THA隐性失血量FG组858.6 mL vs 非FG组1,169.9 mL。
- 输血率TKA FG组4.3% vs 非FG组12.9%;THA FG组8.87% vs 非FG组19.69%。
- 血栓栓塞事件发生率组间无显著差异(P > 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Flowable gelatin (FG) without thrombin is a widely utilized intraoperative hemostatic agent, yet its efficacy in total joint arthroplasty remains debated. This study aimed to assess its clinical impact on total knee arthroplasty (TKA) and total hip arthroplasty (THA). METHODS: We conducted a retrospective analysis of patients who underwent primary TKA and THA at a single institution from 2018 to 2024, categorizing them based on intraoperative FG usage. Patients who received FG were propensity score-matched in a 2:1 ratio to those who did not, based on demographic characteristics, comorbidities, and surgical factors. Primary outcomes included blood loss, transfusion rate, thromboembolic events, and other perioperative complications. Regression analyses were conducted to assess the impact of intraoperative FG use on total blood loss in both TKA and THA. A total of 612 TKA patients (non-FG: 233; FG: 117) and 844 THA patients (non-FG: 391; FG: 203) were included, with a mean follow-up exceeding two years (up to six years). RESULT: Both total blood loss (TKA: 899.0 versus 1,122.1 mL; THA: 1,021.8 versus 1,328.4 mL) and hidden blood loss (TKA: 789.1 versus 1,010.8 mL; THA: 858.6 versus 1,169.9 mL) were significantly reduced in the FG group, accompanied by lower transfusion rates (TKA: 4.3 versus 12.9%; THA: 8.87 versus 19.69%). The incidence of thromboembolic events, including deep vein thrombosis and pulmonary embolism, did not differ significantly between groups (P > 0.05). Multivariate analyses further identified FG use as an independent predictor of reduced total blood loss. CONCLUSIONS: Our study found that FG effectively reduces perioperative blood loss and transfusion rates in both TKA and THA, without increasing the risk of lower limb thrombosis or other postoperative complications. LEVEL OF EVIDENCE: Level II study.
引用
- Zhang Y, Yuan J, Zhang Y, et al. The Application of Flowable Gelatin Without Thrombin in Total Joint Arthroplasty: A Propensity Score-Matched Comparative Study. J Arthroplasty. 2025. PMID: 41205717. doi:10.1016/j.arth.2025.10.122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。